SCHEMBL6063374

SCHEMBL6063374

CCCC(NC(=O)[CH]CS(=O)(=O)Cc1ccccc1)C(O)c1nc2ccccc2o1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.41
PTPN1 P18031 8/20 0.39
PTPN2 P17706 6/20 0.39
HDAC3 O15379 4/20 0.37
HDAC4 P56524 4/20 0.37
HDAC1 Q13547 4/20 0.37
HDAC7 Q8WUI4 4/20 0.37
HDAC2 Q92769 4/20 0.37
HDAC10 Q969S8 4/20 0.37
HDAC11 Q96DB2 4/20 0.37
HDAC8 Q9BY41 4/20 0.37
HDAC6 Q9UBN7 4/20 0.37
HDAC9 Q9UKV0 4/20 0.37
HDAC5 Q9UQL6 4/20 0.37
HSF1 Q00613 2/20 0.35
MAPT P10636 1/20 0.34
HPGD P15428 1/20 0.34
CTSS P25774 2/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6062878 0.84 ALDH1A1 (0.44) ALDH1A1PTPN1PTPN2MAPTHPGD
SCHEMBL5424669 0.84 PTPN1 (0.41) ALDH1A1PTPN1PTPN2HDAC3HDAC4
SCHEMBL6063377 0.84 ALDH1A1 (0.44) ALDH1A1PTPN1PTPN2MAPTHPGD
SCHEMBL5424670 0.84 PTPN1 (0.41) ALDH1A1PTPN1PTPN2HDAC3HDAC4
SCHEMBL6702107 0.83 PTPN1 (0.38) ALDH1A1PTPN1PTPN2MAPTHPGD
SCHEMBL6702111 0.83 PTPN1 (0.38) ALDH1A1PTPN1PTPN2MAPTHPGD
SCHEMBL6695960 0.83 PTPN1 (0.38) ALDH1A1PTPN1PTPN2MAPTHPGD
SCHEMBL6630202 0.83 PTPN1 (0.38) ALDH1A1PTPN1PTPN2MAPTHPGD
SCHEMBL6632738 0.83 PTPN1 (0.38) ALDH1A1PTPN1PTPN2MAPTHPGD
SCHEMBL6695966 0.83 PTPN1 (0.38) ALDH1A1PTPN1PTPN2MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1694357-A1 USE OF CATHEPSIN S INHIBITORS FOR TREATING AN IMMUNE RESPONSE CAUSED BY ADMINISTRATION OF A SMALL MOLECULE THERAPEUTIC OR BIOLOGIC AXYS PHARMACEUTICALS, INC. (US) 2006-08-30 EP disclosed
WO-2005058348-A1 USE OF CATHEPSIN S INHIBITORS FOR TREATING AN IMMUNE RESPONSE CAUSED BY ADMINISTRATION OF A SMALL MOLECULE THERAPEUTIC OR BIOLOGIC AXYS PHARMACEUTICALS, INC. (US) 2005-06-30 WO disclosed